Your browser doesn't support javascript.
loading
Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections.
Bramer, Lisa M; Hontz, Robert D; Eisfeld, Amie J; Sims, Amy C; Kim, Young-Mo; Stratton, Kelly G; Nicora, Carrie D; Gritsenko, Marina A; Schepmoes, Athena A; Akasaka, Osamu; Koga, Michiko; Tsutsumi, Takeya; Nakamura, Morio; Nakachi, Ichiro; Baba, Rie; Tateno, Hiroki; Suzuki, Shoji; Nakajima, Hideaki; Kato, Hideaki; Ishida, Kazunari; Ishii, Makoto; Uwamino, Yoshifumi; Mitamura, Keiko; Paurus, Vanessa L; Nakayasu, Ernesto S; Attah, Isaac K; Letizia, Andrew G; Waters, Katrina M; Metz, Thomas O; Corson, Karen; Kawaoka, Yoshihiro; Gerbasi, Vincent R; Yotsuyanagi, Hiroshi; Iwatsuki-Horimoto, Kiyoko.
Afiliação
  • Bramer LM; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Hontz RD; U.S. Naval Medical Research Unit No. TWO (NAMRU-2), Singapore, Singapore.
  • Eisfeld AJ; Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
  • Sims AC; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Kim YM; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Stratton KG; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Nicora CD; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Gritsenko MA; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Schepmoes AA; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Akasaka O; Emergency Medical Center, Fujisawa City Hospital 2-6-1 Fujisawa, Fujisawa, Japan.
  • Koga M; Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Tsutsumi T; Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Nakamura M; Department of Pulmonary Medicine, Tokyo Saiseikai Central, Tokyo, Japan.
  • Nakachi I; Pulmonary Division, Department of Internal Medicine, Utsunomiya Hospital, Utsunomiya, Japan.
  • Baba R; Pulmonary Division, Department of Internal Medicine, Utsunomiya Hospital, Utsunomiya, Japan.
  • Tateno H; Department of Pulmonary Medicine, Saitama City Hospital, Saitama, Japan.
  • Suzuki S; Department of Pulmonary Medicine, Saitama City Hospital, Saitama, Japan.
  • Nakajima H; Department of Hematology and Clinical Immunology, University School of Medicine, Yokohama, Japan.
  • Kato H; Department of Hematology and Clinical Immunology, University School of Medicine, Yokohama, Japan.
  • Ishida K; Kobe Kaisei Hospital, Kobe, Japan.
  • Ishii M; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Uwamino Y; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Mitamura K; Division of Infection Control, Eiju General Hospital, Tokyo, Japan.
  • Paurus VL; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Nakayasu ES; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Attah IK; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Letizia AG; U.S. Naval Medical Research Unit No. TWO (NAMRU-2), Singapore, Singapore.
  • Waters KM; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Metz TO; Pacific Northwest National Laboratory, Richland, WA, USA.
  • Corson K; U.S. Naval Medical Research Unit No. TWO (NAMRU-2), Singapore, Singapore.
  • Kawaoka Y; Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
  • Gerbasi VR; Department of Microbiology and Immunology, Japan.
  • Yotsuyanagi H; International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Iwatsuki-Horimoto K; Pacific Northwest National Laboratory, Richland, WA, USA.
Heliyon ; 9(3): e13795, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36915486
ABSTRACT
The detailed mechanisms of COVID-19 infection pathology remain poorly understood. To improve our understanding of SARS-CoV-2 pathology, we performed a multi-omics and correlative analysis of an immunologically naïve SARS-CoV-2 clinical cohort from blood plasma of uninfected controls, mild, and severe infections. Consistent with previous observations, severe patient populations showed an elevation of pulmonary surfactant levels. Intriguingly, mild patients showed a statistically significant elevation in the carnosine dipeptidase modifying enzyme (CNDP1). Mild and severe patient populations showed a strong elevation in the metabolite L-cystine (oxidized form of the amino acid cysteine) and enzymes with roles in glutathione metabolism. Neutrophil extracellular traps (NETs) were observed in both mild and severe populations, and NET formation was higher in severe vs. mild samples. Our correlative analysis suggests a potential protective role for CNDP1 in suppressing PSPB release from the pulmonary space whereas NET formation correlates with increased PSPB levels and disease severity. In our discussion we put forward a possible model where NET formation drives pulmonary occlusions and CNDP1 promotes antioxidation, pleiotropic immune responses, and vasodilation by accelerating histamine synthesis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article